Siemens-Varian deal may prompt US antitrust look at radiation oncology market
Siemens Healthineers' planned $16.4 billion acquisition of Varian Medical Systems will likely prompt US antitrust review of the companies' offerings in the radiation oncology space, an area in which the firms...
Subscription required to view this article.This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: